Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Single-dose vs Split-dose Ergocalciferol for Vitamin D Inadequacy in Postmenopausal Osteoporosis
TCTR20250713001Phase 3Recruiting
- Sponsor
- Maha Vajiralongkorn Foundation
- Start
- Jun 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of vitamin d in osteoporosis and Vitamin D deficiency (VDD) (2 arms), sponsored by Maha Vajiralongkorn Foundation. Primary endpoint: Correction of vitamin D inadequacy. Started Jun 2025; status: recruiting.
02
Drugs
vitamin d
03
Conditions
osteoporosisVitamin D deficiency (VDD)
Beyond the preview
Go deeper on TCTR20250713001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250713001.